IBDEI05B ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6827,1,3,0)
 ;;=3^DM type II w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,6827,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,6827,2)
 ;;=DM type II w/o Eye Disease^33605
 ;;^UTILITY(U,$J,358.3,6828,0)
 ;;=346.90^^37^407^41
 ;;^UTILITY(U,$J,358.3,6828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6828,1,3,0)
 ;;=3^Headache,Migraine-Not Intractable
 ;;^UTILITY(U,$J,358.3,6828,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,6828,2)
 ;;=Migraine without Intract^293880
 ;;^UTILITY(U,$J,358.3,6829,0)
 ;;=376.30^^37^407^30
 ;;^UTILITY(U,$J,358.3,6829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6829,1,3,0)
 ;;=3^Exophthalmos,NOS
 ;;^UTILITY(U,$J,358.3,6829,1,4,0)
 ;;=4^376.30
 ;;^UTILITY(U,$J,358.3,6829,2)
 ;;=Exophthalmos NOS^43683
 ;;^UTILITY(U,$J,358.3,6830,0)
 ;;=368.8^^37^407^7
 ;;^UTILITY(U,$J,358.3,6830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6830,1,3,0)
 ;;=3^Blurred Vision
 ;;^UTILITY(U,$J,358.3,6830,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,6830,2)
 ;;=Blurred Vision^88172
 ;;^UTILITY(U,$J,358.3,6831,0)
 ;;=362.34^^37^407^5
 ;;^UTILITY(U,$J,358.3,6831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6831,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,6831,1,4,0)
 ;;=4^362.34
 ;;^UTILITY(U,$J,358.3,6831,2)
 ;;=^268622
 ;;^UTILITY(U,$J,358.3,6832,0)
 ;;=368.13^^37^407^88
 ;;^UTILITY(U,$J,358.3,6832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6832,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,6832,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,6832,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,6833,0)
 ;;=368.40^^37^407^113
 ;;^UTILITY(U,$J,358.3,6833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6833,1,3,0)
 ;;=3^Vis Field Defect
 ;;^UTILITY(U,$J,358.3,6833,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,6833,2)
 ;;=^126859
 ;;^UTILITY(U,$J,358.3,6834,0)
 ;;=369.4^^37^407^58
 ;;^UTILITY(U,$J,358.3,6834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6834,1,3,0)
 ;;=3^Legally Blind,USA Definition
 ;;^UTILITY(U,$J,358.3,6834,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,6834,2)
 ;;=Legal Blindness^268887
 ;;^UTILITY(U,$J,358.3,6835,0)
 ;;=250.01^^37^407^21
 ;;^UTILITY(U,$J,358.3,6835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6835,1,3,0)
 ;;=3^DM Type I w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,6835,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,6835,2)
 ;;=Diabetes Mellitus Type I^33586
 ;;^UTILITY(U,$J,358.3,6836,0)
 ;;=V08.^^37^407^40
 ;;^UTILITY(U,$J,358.3,6836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6836,1,3,0)
 ;;=3^HIV Positive
 ;;^UTILITY(U,$J,358.3,6836,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,6836,2)
 ;;=Asymptomatic HIV Status^303392
 ;;^UTILITY(U,$J,358.3,6837,0)
 ;;=921.0^^37^407^16
 ;;^UTILITY(U,$J,358.3,6837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6837,1,3,0)
 ;;=3^Contusion of Eye
 ;;^UTILITY(U,$J,358.3,6837,1,4,0)
 ;;=4^921.0
 ;;^UTILITY(U,$J,358.3,6837,2)
 ;;=^15052
 ;;^UTILITY(U,$J,358.3,6838,0)
 ;;=379.91^^37^407^87
 ;;^UTILITY(U,$J,358.3,6838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6838,1,3,0)
 ;;=3^Pain in/around the Eye
 ;;^UTILITY(U,$J,358.3,6838,1,4,0)
 ;;=4^379.91
 ;;^UTILITY(U,$J,358.3,6838,2)
 ;;=Pain in or around eye^89093
 ;;^UTILITY(U,$J,358.3,6839,0)
 ;;=V58.69^^37^407^44
 ;;^UTILITY(U,$J,358.3,6839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6839,1,3,0)
 ;;=3^Hi-Risk Med,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,6839,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,6839,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,6840,0)
 ;;=871.4^^37^407^54
 ;;^UTILITY(U,$J,358.3,6840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6840,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,6840,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,6840,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,6841,0)
 ;;=242.90^^37^407^108
 ;;^UTILITY(U,$J,358.3,6841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6841,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,6841,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,6841,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,6842,0)
 ;;=135.^^37^407^101
 ;;^UTILITY(U,$J,358.3,6842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6842,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,6842,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,6842,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,6843,0)
 ;;=446.5^^37^407^107
 ;;^UTILITY(U,$J,358.3,6843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6843,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,6843,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,6843,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,6844,0)
 ;;=401.9^^37^407^49
 ;;^UTILITY(U,$J,358.3,6844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6844,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,6844,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,6844,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,6845,0)
 ;;=V72.0^^37^407^32
 ;;^UTILITY(U,$J,358.3,6845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6845,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,6845,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,6845,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,6846,0)
 ;;=V41.0^^37^407^91
 ;;^UTILITY(U,$J,358.3,6846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6846,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,6846,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,6846,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,6847,0)
 ;;=998.59^^37^407^89
 ;;^UTILITY(U,$J,358.3,6847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6847,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,6847,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,6847,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,6848,0)
 ;;=042.^^37^407^1
 ;;^UTILITY(U,$J,358.3,6848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6848,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,6848,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,6848,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,6849,0)
 ;;=053.29^^37^407^43
 ;;^UTILITY(U,$J,358.3,6849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6849,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,6849,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,6849,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,6850,0)
 ;;=054.40^^37^407^42
 ;;^UTILITY(U,$J,358.3,6850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6850,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,6850,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,6850,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,6851,0)
 ;;=190.1^^37^407^83
 ;;^UTILITY(U,$J,358.3,6851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6851,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,6851,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,6851,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,6852,0)
 ;;=190.2^^37^407^50
 ;;^UTILITY(U,$J,358.3,6852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6852,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,6852,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,6852,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,6853,0)
 ;;=190.7^^37^407^52
 ;;^UTILITY(U,$J,358.3,6853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6853,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,6853,1,4,0)
 ;;=4^190.7
 ;;^UTILITY(U,$J,358.3,6853,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,6854,0)
 ;;=202.81^^37^407^61
 ;;^UTILITY(U,$J,358.3,6854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6854,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,6854,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,6854,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,6855,0)
 ;;=215.9^^37^407^85
 ;;^UTILITY(U,$J,358.3,6855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6855,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,6855,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,6855,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,6856,0)
 ;;=224.2^^37^407^51
 ;;^UTILITY(U,$J,358.3,6856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6856,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,6856,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,6856,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,6857,0)
 ;;=224.5^^37^407^96
 ;;^UTILITY(U,$J,358.3,6857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6857,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,6857,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,6857,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,6858,0)
 ;;=224.7^^37^407^28
 ;;^UTILITY(U,$J,358.3,6858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6858,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,6858,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,6858,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,6859,0)
 ;;=237.70^^37^407^66
 ;;^UTILITY(U,$J,358.3,6859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6859,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,6859,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,6859,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,6860,0)
 ;;=239.6^^37^407^65
 ;;^UTILITY(U,$J,358.3,6860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6860,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,6860,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,6860,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,6861,0)
 ;;=239.81^^37^407^97
 ;;^UTILITY(U,$J,358.3,6861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6861,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,6861,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,6861,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,6862,0)
 ;;=272.0^^37^407^48
 ;;^UTILITY(U,$J,358.3,6862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6862,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,6862,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,6862,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,6863,0)
 ;;=340.^^37^407^63
 ;;^UTILITY(U,$J,358.3,6863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6863,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,6863,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,6863,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,6864,0)
 ;;=345.90^^37^407^29
 ;;^UTILITY(U,$J,358.3,6864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6864,1,3,0)
 ;;=3^Epliepsy,Unspec
